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The objective of the present work is to study the possibility of involved neurotransmitters in the CNS 
side effects due to the administration of Pentoxifyllin in male albino rats. The frontal cortex of 
Pentoxifyllin treated groups revealed decrease of glutamate, GABA and elevation of aspartate, 
asparagines, glycin, serine levels and AChE activities in a time related effect. In the hippocampus area 
there are elevation of asparaginet, GABA, glycine, serine level but reductions of glutamate, aspartate 
level and AChE activities in a time related effect. Overall, the data suggest that there is a shift in the 
balance between neurotranamitters towards increased production of excitatory potency in groups 
subjected to Pentoxifyllin administration. 
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glutamate, Aspartate level. 









The nervous system regulates all aspects of bodily function. It is staggering in its complexity. Despite of the 
complexity of the nervous system we known, for instance, those electrical impulses are produced along the length of 
every nerve cell. A neurotransmical is defined as a chemical that is selectively released from a nerve terminal by an 
action potential, interacts with a specific receptor on an adjacent structure and elicits a specific physiological 
response [1]. Neurotransmitters are chemicals that are released from nerve endings into the synapse, Where they 
produce effects by binding to receptors on postsynaptic.The receptors may be on other neurons of effectors ′organs 
such as smooth muscle [2]. 
Neurotransmitters are classified into groups of substances within chemical categories: amino acids [3] 
catecholamine [4] and neuropeptides [5]. Other substances that may participate in central synaptic transmission 
include purines such as adenosine and ATP [6]. 
Fonnum [7] cited that the majority of the synapses in the brain, and perhaps as many as 90% use amino acids as 
transmitters. Now, amino acids transmitters involved in most brain functions, and amino acids are the prime 
mediators of fast synaptic signaling. Glutamate is the most common neurotransmitter in the brain [8], Asparate is an 
excitatory neuro transmitter [9], Asparagine is a non essential amino acid which is made from aspartic acids plus 
ATP (adenosine tri-phosphate) [10]. 
GABA (Y-amino butyric acid) was identified as unque chemical constituent of brain in 1950, but its potency as a 
CNS depressant was not immediately recognized [11]. Glycine acts as a post-synaptic inhibitory transmitter in the 
spinal cord and brain stem [12]. Serine has been proposed to act as a neurotransmitter(inhibitory amino acids) [13]. 
Antibiotics are among the most frequently prescribed medications in modern medicine. Antibiotics cure disease 
by killing or injuring bacteria.The present study aimed to evaluate the impact of oral administration of Pentoxifyllin 
on the levels of amino acids neurotransmitter (Glutamate, Asparate, Asparagine, GABA, Glycine, Glycine Glycine) 
and acetylecholinesterase activities in the frontal cortex and the hippocampus of brain areas of adult male albino rats 
(Rattusnorvegicus) through 1,3,7 and 14 days post Pentoxifyllin administration. 
 
2. Material and Methods  
2.1. Drug and Doses 
Pentoxifylline (PTX) (Trental ®, Aventis Pharma, Cairo, Egypt), was orally administered 4 wks post infection (PI) 
5 days/wk at dose of 400 mg/Kg body weight. The treatment was continued until the date of sacrifice. 
 
2.2. Experimental Animals 
This study was carried out on adult male albino rats (Ratusnorvegicus). One hundred eight animals with average 
weight ranged 100g ± 20g. They were obtained from the Egyptian Institution of Serum and Vaccine (Helwan). 
The male albino rats were housed in iron mesh cages with seven rats each. Clean sawdust was used to keep the 
animals dry and clean throughout the experimental periods. The experimental animals were allowed to acclimate 
under the laboratory conditions two weeks before the beginning of the experiments. The animals were kept under 
controlled temperature of 21oC and 12 hours light 12/hours dark cycle throughout the course of experiment. A 
commercial pelleted diet and fresh vegetables were used before the experiment. The food debris, feces and urine 
were removed daily to prevent food and water contamination. 
 
2.3. Experimental Design 
In order to study the physiological effect of  Pentoxifyllin  on the levels of amino acids and monoamines 
neurotransmitters and activities of acetylcholinesteras in frontal cortex and hippocampus brain areas. The rats 
divided into three main groups. The rats of the first group (n=12 rats) were administered 2 ml of distilled water daily, 
whereas those of the second group(n=48 rats) were administered 400 mg/Kg body weight Pentoxifyllin dissolved in 
2 ml water.At the end of the experimental periods 1, 3, 7 and 14 days, twelve animals sacrificed after 12 hours from 
the last administration by rapid decapitation. The brains were dissected out quickly weighed and cleaned. Four brains 
from each treated group served for biochemical analysis. For biochemical analysis and in case of control group three 
animals were selected at each experimental period to achieve a single control group representing the control of the 
study. The frontal cortex and hippocampus brain areas were separated from each whole brain. Each brain area 
divided into two halves the first half served for acetylcholinesterase activity assay and the second half was 
homogenized in 75% high performance liquid chromatography (HPLC) methanol (1/10) weight/volume) using a 
homogenizer surrounded with an ice jacket and the homogenates and used for the determination of the brain contents 
of amino acids and monoamines neurotransmitters. 
 
2.4. Estimation of the Biochemical Parameters 
2.4.1. Estimation of the Free Amino Acids 
Free amino neurotransmitters were estimated by aid of high performance liquid chromatography (HPLC), using 
the precolumn PTC derivatization technique according to method of Heinrikson and Meredith [14]. 
The amino acids (glutamic acids, aspsrtic acids, asparagines, GABA (y-amino-butyric acids), glycine and 
serine,) were determined in the brain cortex and hippocampus. 
Derivatized amino acids standard and derivatized sample were injected, the injected volume is 20µl into the 
column for separation by HPLC. The resulting chromatogram identified each amino acids position and concentration 
from the sample as compared to that of the amino acids standard and finally the determination of the µ mole content 
of each amino acids per gram brain tissue was achieved.  The chromatogram was integrated by Turbochrome 
software program [Perkin-Elmer, USA]. The brain content of each amino acid was expressed as µmol/g tissue and 
was calculated using the following formula: 
 








2.4.2. Estimation of Acetylcholinesterase (AChE) Activity 
Acetylcholinesterase activity in the brain cortex and hippocampus were determinate according to the modified of 
Ellman, et al. [15] method as described by Gorum, et al. [16]. The principle of the method is based on measurement 
of the rate of thiocholine as a result of Acetylthiocholinehydrolysis.The reagents (analytical grade) were phosphate 
buffer, pH 7.6 (20 mmol), acetylthiocholine iodide (5mmol). DTNB-phosphate- ethanol reagent (12.4 mg 5,5-
dithiobis-2-nitrobenzoic acid dissolved in 120 ml of 96% ethanol, 80 ml of distilled water and 50 ml of 0.1 M 
phosphate buffer, pH 7.6). the solution can be kept at room temperature for at least six months. Glutathione 
(2.5mmol) was used as a standard for cholinesterase activity. 
The brain cortex and hippocampus tissue samples were weighed and homogenized in a 20 mmol- phosphate 
buffer, pH 7.6 (4%w.v). 0.14 ml phosphate buffer 20 mmpl pH 7.6), 0.05 ml 5-mmol-acetylthiocholine iodide and 
0.01 ml of tissue homogenate were pipettes in a cuvette that incubated for 10 min at 38oC, then the reaction was 
stopped by 1.8 ml of DTNB-phosphate ethanol reagent. The color produced was read immediately at 412 nm on 
Shimadzu apectrophotometer uv-1601. The cholinesterase was determined as µmolsh from a standard curve. 
 
3. Result 
3.1. Biochemical Studies 
3.1.1. Effect of Pentoxifyllinon Glutamic Acid Concentration in Frontal Cortex and Hippocampus 
Tissues 
3.1.1.1. Frontal Cortex 
Data presented in Table (1) recorded the effect of Pentoxifyllin on glutamic acid concentration in the frontal 
cortex of male albino rats. The data showed a significant decrease throughout the experimental periods which is 
inversely proportional to the duration as the maximum effect achieved after the 1st injection of   and exhibited 55.4, 




Data presented in Table (1) recorded the effect of Pentoxifyllin On glutamic acid concentration in the 
hippocampus tissue of male albino rats. The data showed significant decrease in the 1st,3th,  7th and 14th days of the 
experimental periods as compared with the control.  Administration of Pentoxifyllin and exhibited 10.4, 7.3, 5.2 and 
1.04% percentage difference from control value after experimental durations 1, 3, 7 and 14 days, repectively. 
 
Table-1. Effect Pentoxifyllin of the levels of glutamic (µmole/g) in frontal and hippocampus of the cortex of male albino rats 
 
 
Table-2. Effect Pentoxifyllin of the levels of aspartic acid (µmole/g) in frontal and hippocampus of the cortex of male albino rats 
 
 
Table-3. Effect Pentoxifyllin of the levels of asparagine (µmole/g) in frontal and hippocampus of the cortex of male albino rats 
 
 
Table-4. Effect Pentoxifyllin of the levels of serine (µmole/g) in frontal and hippocampus of the cortex of male albino rats 
 
 












Table-6. Effect Pentoxifyllin of the levels of glycine (µmole/g) in frontal and hippocampus of the cortex of male albino rats 
 
 
Table-7. Effect Pentoxifyllin of the levels of AchE (µmole/g) in frontal and hippocampus of the cortex of male albino rats 
 
 
3.1.2. Effect of Pentoxifyllin on Aspartic Acid Concentration in Frontal Cortex and Hippocampus 
Tissues 
Collection data of aspartic acid concentrations in the frontal cortex and hippocampus tissues of male albino rats 
affected by Pentoxifyllin administration are given in Table (2).  
 
3.1.2.1. Frontal Cortex 
The data in Table (2) showed a significant increase (P<0.05) throughout the experimental durations and the 
maximum effect achieved after 14 days post Pentoxifyllin Treatment and exhibited 22.29, 25.48, 43.31, and 55.1 
percentage difference from control value after experimental durations 1, 2, 7 and 14 days, respectively.  
 
3.1.2.2. Hippocampus 
Data presented in table (2) recorded the effect of Pentoxifyllin on aspartic acid concentration in the hippocampus 
tissue of male albino rats. The data showed significant decrease in the 1st,3rd and 7th days in Pentoxifyllin 
Administered groups.But after the 14th day of drug administration aspirate elevated restoring to some extent it´s 
control value. Administration of Pentoxifyllin exhibited -26.46, -12.68, -7.98 and -1.41 Percentage difference from 
control value after experimental duration 1, 2, 7 and 14 days respectively.  
 
3.1.3. Effect of Pentoxifyllinon Asparagine Concentration in Frontal Cortex and Hippocampus 
Tissues 
The general pattern about the data of asparagines concentrations in the frontal cortex and hippocampus tissues of 
male albino rats affected by Pentoxifyllin administration are given in Table (3)  
 
3.1.3.1. Frontal Cortex 
The data in Table (3) showed  asparagines level increased significantly from the 3rd days of   Pentoxifyllin 
administration till the last 14th day as compared to the control value in the frontal cortex recording the percentage 
differences -3.7%,10.71, -19.64and-32.14 at the  increase (P<0.05) the 1st,3rd and 7th days, respectively,  
 
3.1.3.2. Hippocampus 
Data recorded in Table (3) represented the effect of Pentoxifyllin on asparagines concentration in the 
hippocampus tissue of male albino rats. The data showed significant increase from the 1st to the 14th day of 
Pentoxifyllin administration. Administration of Pentoxifyllin exhibited 33.3, 58.3%, 70.83% and 75 percentage 
difference from control value after experimental duration 1,2,7 and 14 days respectively.  
 
3.1.4. Effect of Pentoxifyllinon Serine Concentration in Frontal Cortex and Hippocampus Tissues 
3.1.4.1. Frontal Cortex 
The general pattern about the data of serine concentrations in the frontal cortex of male albino rats affected by 
Pentoxifyllin administration are given in Table 4. Pentoxifyllin administration exhibited significant increase after the 
1st dose by 65.63 % percentage change from control value. Serine frontal cortex level increased then decreased 
insignificantly, at the, 3rd and 7th duration representage 58.83 and 6.25 as percentage difference from control level. 
At the last duration serine level increased significantly by 21.88 Percentage changes from control value (Table 4).  
 
3.1.4.2. Hippocampus 
Data presented in Table 4. Recorded the effect of Pentoxifyllin on serine concentrations in the hippocampus 
tissue of male albino rats. The data showed significant increase after the 1st day Pentoxifyllin  administered group as 
compared to control level. But after the 7th day of drug administration serine decreased significantly as compared to 
its control value. Then serine level increased significantly after the 14th day of Pentoxifyllin administration 
compared to control (<0.05). Administration of Pentoxifyllin exhibited 61.54 , 38.46, 15.38 and 53.85 percentage 
difference from value after experimental duration 1,2,7.and 12 days, respectively. 
 
3.1.5. Effect of Pentoxifyllinon GABA Concentration in Frontal Cortex and Hippocampus Tissues 
The general pattern about the dat of GABA concentrations in the frontal cortex and hippocampus tissues of male 
albino rats affected by Pentoxifyllin administration are giPentoxifyllinven in Table 5. 
 








3.1.5.1. Frontal Cortex 
GABA concentration decreased significantly (P<0.05) as compared to the control level from the 1st day of 
Pentoxifyllin administration till the 14 th day post administration. The data revealed -26.82, -23.64, -25.91 and -19.1 
percentage difference from control value after experimental duration 1,2,3,7 and 14 days,respectively(Table 5 ). 
 
3.1.5.2. Hippocampus 
The data presented in Table 5. Recorded the effect of Pentoxifyllin concentration in the hippocampus tissue of 
male albino rats. The data showed significant increase throughout of the experimental periods post Pentoxifyllin 
administration in the GABA levels as compared to the control value. The data revealed 15.63, 21.25, 37.5 and 62.5 
percentage difference from control value after experimental duration 1,2,7 and 14 days, respectively 
 
3.1.6. Effect of Pentoxifyllinon Glycine Concentration in Frontal Cortex and hippocampus Tissues 
The general pattern about the data of glycine concentrations in the frontal cortex and hippocampus tissues of 
male albino rats affected by Pentoxifyllin administration are given in Table 6. 
 
3.1.6.1. Frontal Cortex 
Data presented in Table 6 showed that glycine concentration increased significantly (P<0.05) as compared to the 
control level from the 1th day of Pentoxifyllinadminstration  till the end of the expermintal periods. The data 




Data presented in Table (6) recorded the effect of Pentoxifyllin on glycine concentration in the Hippocampus 
tissue of male albino rats. The data showed significant increase from the 1st day in Pentoxifyllin administrated group 
as compared to control level till the 14th day of drug administration. Administration Pentoxifyllin exhibited 14, 
40.35, 61.4 and 84.2 percentage difference from control value after expermintal duration 1,2,5 and 14 
dayss,respectively. 
 
3.1.7. Effect of Pentoxifyllinon Acetylcholinesterase (AchE) Concentration in Frontal Cortex and 
Hippocampus Tissues 
The general pattern the data of AchE activity in the frontal cortex and Hippocampus tissues of male albino rats 
affected by Pentoxifyllin administration are givein in Table (7). 
 
3.1.7.1. Frontal Cortex 
The data in Table 7 showed dose response significant increase (P<0.05) in AchE activity from 1st achieving the 
maximum activity in the 14th doses of Pentoxifyllin treatment as compared to the control enzyme activity 




Data presented in Table 7 recorded the effect of Pentoxifyllin on AchE activity in the Hippocampus tissue of 
male albino rats. The data showed significant decrease in AchE activity from the 1st till the 14th day´ 
Pentoxifyllinadministration groups as compared to the control enzyme activity. The data revealed -11.1, -14.4, -23.9 
and -37.8 percentage difference from control value after expermintal duration 1,3,5 and 14 dayss, respectively. 
 
4. Discussion 
In the present study the response of cortex and hippocampus areas to Pentoxifyllin at different duration are 
clearly investigated through the determined amino acids monoamines neurotransmitters and the recorded activities of 
the acetylcholinesterase enzyme and the excitatory potencies of Pentoxifyllin recorded throw the elevation ofaspartic  
and asparagines level and the increase of the activities of AchE  in spite of decrease glutamic level I the cortical area 
as a result of Pentoxifyllin administrations in a time related effect. In addition there is decrease GABA level in a 
manner as aforementioned effect. 
The excitatory potencies of the antibiotics under investigation varied as regard to the hippocampus area where 
Pentoxifyllin in the hippocampus area recorded elevation of asparagines, GABA, serine, glycine levels but decrease 
of glutamate level in a time related effect. In addition there is decrease of AchE activities and aspartate, glutamate 
levels in a dose related effect. 
The previous finding, which recorded in brain cortical areas from groups subjected to the antibiotics, is in line 
with alterations in extrahippocampal regions in epileptic rat models. This alterations support the  extrahippocampal 
with GABAergic inhibition [17].  
The alterations in the hippocampus area evidence provided links early sezures with the later development of 
epilepsy and selective hippocampus neuronal loss [18]. 
The anexiogenic effects due to hippocampus may be supported through the recorded changes in the 
concentrations of frontal cortex amino acid. There were decreases in GABA and glutamate levels with a concomitant 
increase in aspartate, asparagines, glycine and serine contents which similar to those recorded in the frontal cortex of 
epileptic rat models [19, 20]. 
The regional differences in GABA level and acetylcholinesterase activity between decrease of GABA level  and 
increase of AChE activity in the cortical area and increase of GABA level and decrease of AChE  activity in the 
hippocampal area in antibiotic  treated groups in a dose related effect which mimics that predicted in rat epileptic 








models [21] and support the proconvulsant effect of the quino;ones previously discussed [22]. Biochemical studies 
have proposed a role for AChE in brain mechanisms responsible by development to status epilepticus through 
decrease in the n the hippocampus [23]. 
The decreased glutamate level in the cortical area of Pentoxifyllin treated groups and treated group hippocampus 
area, may be explained as fluoroquinolones did not bind to the glutamate or glycine-binding site of the NMDA 
receptor. It has been shown that fluoroquinolonesand MK-801 binding to the NMDA receptor [24]. The decrease of 
glutamate and increase of aspartate may be explained through the glucose homeostasis abnormalities (dysglycemia) 
associated with the use of Pentoxifyllin [25]. 
The elevated level of glycine in cortical and hippocampus areas of rats subjected to Pentoxifyllin may be 
declared the effect of the inhibitory neurotransmitter glycine on slow destructive processes in brain cortex slices 
under anoxic conditions as glycine, the simplest of the amino acids, is an essential component of important biological 
molecules, a key substance in many metabolic reactions,the major inhibitory neurotransmitter in the spinal cord and 
brain stem, and an anti-inflammatory,cytoprotective [26, 27]. In hippocampus area the experimental model of 
epilepsy during kianic acid induced epilepsy the results indicated that the levels of glutamate,aspartate, glycine and 
GABA were ststistically increased in rat′s hippocampus [28]. 
 As regard to the recorded data about the amino acid serine Kartvelishvily, et al. [29] study suggestion may 
declare the mechanism through which the serine concentration elevated in the frontal cortex of the antibiotics treated 
as D-serine is a co-agonist of N-methyl-D-aspartate (NMDA) RECEPTORS that occurs at high levels in the brain. 
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